The use of anabolic steroids has become increasingly prevalent in sports and fitness communities. While short-term benefits may include gains in muscle size and strength, long-term steroid use poses serious health risks that far outweigh any perceived performance or cosmetic benefits. This paper will explore the physiology behind steroid use, recognized adverse health effects, and ethical considerations surrounding their use in athletics and bodybuilding. The goal of this research is to provide a comprehensive overview of the current scientific understanding of steroid use and health in order to argue that the health risks of anabolic steroids greatly outweigh any benefits, making long-term use an unsafe and unethical choice for performance enhancement or physique goals.
Anabolic steroids are a class of synthetic compounds similar in chemical structure to testosterone, the primary male sex hormone. When taken in pharmacologic doses, these androgenic-anabolic steroids (AAS) promote the growth of skeletal muscle and the development of male sexual characteristics. The mechanisms of action that stimulate muscle and strength gains also incur health risks through their effects on other organ systems (Bhasin et al., 1996). Fundamentally, steroid use artificially elevates levels of hormones intended to operate within a finely-tuned physiological range. Disturbances in this homeostasis often manifest as adverse health effects.
AAS work by binding to and activating androgen receptors throughout the body. This results in increased protein synthesis, nitrogen retention, and IGF-1 expression – all of which promote an anabolic, or tissue-building, environment favoring muscle hypertrophy when combined with strength training (Bhasin et al., 1996). Strength and muscle mass increases are typically seen within the first few weeks of AAS administration and can range from 5-20% depending on training status and steroid regimen (Bhasin et al., 1996). These gains often diminish or disappear entirely following cessation of use as natural hormonal levels have been suppressed.
While muscularly beneficial in the short-term, AAS introduce health risks through several mechanisms including virilizing effects, changes to lipid profiles, cardiovascular strain, and liver toxicity. Testosterone and its synthetic analogues increase secretion of luteinizing hormone (LH) from the pituitary gland, which normally provides feedbackregulation of endogenous testosterone production. Supraphysiologic levels from exogenous steroids overwhelm this negative feedback, suppressing the hypothalamic-pituitary-gonadal (HPG) axis and halting natural testosterone synthesis (Bhasin et al., 1996). This can lead to hormonal imbalances and infertility in both sexes.
Additional “masculinizing” effects like acne, oily skin, body/facial hair growth, and male pattern baldness are linked to androgenic receptor activity. These secondary sex characteristics, while possibly desirable for some, can negatively impact quality of life. A study by Pope et al. (2014) found high-dose AAS abusers exhibited more severe depressive and bipolar symptoms than non-using weightlifters, suggesting mental health risks as well. Aggression and “roid rage,” though often exaggerated, may result from steroid-induced changes in brain chemistry and neurotransmitter levels.
Cardiovascular strain poses one of the most serious health dangers of steroid abuse. AAS adversely modify lipid profiles by increasing low-density lipoprotein (LDL) cholesterol and triglycerides while decreasing protective high-density lipoprotein (HDL). These dyslipidemic effects are proportional to dosage and compound type (Hartgens & Kuipers, 2004). Over time, elevated serum lipids can accelerate atherosclerosis or hardening of the arteries, increasing risks for heart attack, stroke, and cardiac arrest. Prospective long-term studies corroborate this link, reporting cardiac mortality rates two to three times higher in AAS users vs. non-users even after adjusting for confounding lifestyle factors like smoking and inactivity (Laure et al., 2005; Friedl et al., 1989).
Additionally, steroid abusestrainsheart through direct cardiac structural changes like left ventricular hypertrophy (LVH). This thickening of the heart wall is initially compensatory, allowing the organ to generate greater force with each contraction to accommodate increased muscle mass. Sustained LVH becomes maladaptive, impairing cardiac function through altered diastolic filling and increasing strain on the coronary arteries (Hartgens & Kuipers, 2004). Studies utilizing ultrasound and MRI have demonstrated doserelated increases in LV wall thickness even after short cycles of AAS (Andersen et al., 2014; Rocha et al., 2019). Over time, these cardiac alterations may manifest clinically as arrhythmias, heart failure, cardiomyopathy, or sudden death.
Significant adverse effects are seen in the liver as well. Oral AAS like Dianabol and Winstrol are 17-alpha-alkylated, meaning they resist breakdown by the liver during first-pass metabolism. While this bolsters bioavailability, it also introduces hepatotoxicity through formation of toxic metabolites. Chronic elevation of liver enzymes, steatosis or fatty infiltration, and even malignant neoplasms have all been tied to AAS misuse (Kanter & Barnes, 2018). Alarmingly, a recent longitudinal study found over 20% of death certificates for AAS abusers listed liver disease as the primary cause of mortality (Rigotti et al., 2002). Particular concern surrounds injectable hormone cocktails and “stacking” multiple oral compounds, practices which maximally tax hepatocellular synthetic and detoxification pathways.
The effects of AAS abuse on physical and mental health pose tremendous ethical concerns, especially considering usage rates among adolescents and athletes. In a 2013 study by Johnston et al., 2.5% of US high school seniors admitted lifetime steroid use, with rates nearly double for males versus females. Additional surveys indicate over 3 million Americans aged 12 and older have tried steroids at least once (Johnston et al., 2014). Perhaps most alarmingly, 30-60% of steroid-using adolescents may transition to opioid or “hard drug” abuse later in life according to prospective cohort investigations (Elliot et al., 2008; Kanayama et al., 2009). Thus, casual experimentation with steroids during formative developmental periods risks sculpting neurological pathways priming later substance abuse disorders.
Given the well-established adverse physiological consequences detailed here, no ethical sports organization or coach could condone doping in talent Identification or elite competition settings. Performance gains from AAS abuse ultimately derive not from training or dedication, but dangerous pharmaceutical manipulation inconsistent with the spirit and rules of fair play. While cosmetic or recreational motivations differ pragmatically, informed individuals would still question whether transient muscle or appearance changes warrant long-term health jeopardy. Responsible anti-doping authorities reasonably ban performance-enhancers to safeguard athlete welfare, fairness of competition, and the integrity of their respective sports.
A wealth of scientific literature has clearly elucidated serious cardiac, hepatic, endocrine and mental health dangers from long-term anabolic steroid exposure. While initial strength and size increases may seem alluring, those benefits are transient and come at profound cost to overall well-being. Ethically, recreational or performance-motivated steroid use cannot be condoned or encouraged due to violations of personal ethics, sportsmanship, and public health guidelines aimed at preventing abuse and dependence. Given the preponderance of evidence demonstrating cardiopulmonary, oncological, and developmental risks of AAS, it is the position of this paper that the health hazards of anabolic steroid use greatly outweigh any perceived athletic or cosmetic benefits, rendering long-term misuse an unsafe choice for body image or performance goals. Further scientific inquiry and public health initiatives educating youth on these risks are clearly still needed to curb dangerous experimentation before patterns of later substance abuse take hold.
This paper aimed to comprehensively summarize the current scientific understanding of anabolic steroid physiology, adverse health effects, patterns of abuse, and associated ethical concerns. The evidence presented robustly supports the thesis statement that the health risks of steroid misuse far exceed any potential gains in muscle, strength or appearance. Recognition and prevention of hazardous behaviors early on represents the surest path towards optimizing long-term wellness for active populations engaging in sports, fitness or image-related activities. Ongoing diligence from regulatory bodies, healthcare professionals, coaches and communities remains paramount to protecting individuals from avoidable health jeopardy down the road.
Andrew Stroud